Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01771237 · ClinicalTrials.gov registry record · NA

HIV Prevention Among Vulnerable Male Youth

A NA study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

Completed
Registry status
NA
Development phase
121
Enrollment target

NCT01771237 is a NA study that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 121 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01771237, a NA study, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

COMPLETED
Registry status
NA
Development phase
121 participants
Enrollment target

Study Summary

This exploratory study aims to design and test an HIV prevention intervention for young men who have sex with men (MSM) between the ages of 16-20 as this group comprises the US adolescent population most at-risk for HIV infection through sexual contact. To help develop the content and format of our intervention we will first conduct in-depth interviews with twenty-one 18 to 24 year-old young MSM who acquired HIV through male-to-male sexual contact between ages 16-20 (i.e., the target age of our intended intervention). We will then design a group-based primary intervention for young MSM between ages 16-20, relying on the information we gathered from these interviews, as well as consultation from an advisory board of young MSM and HIV prevention experts. Last, we will use an experimental design to compare our intervention to a control condition. We hypothesize that, relative to a control condition of sexual health education and risk reduction, participants in our intervention will demonstrate lower rates of HIV risk behavior, find participation more feasible, and endorse greater acceptability of our intervention.

Interventions

  • BEHAVIORAL MyPeeps Manualized Group Intervention
  • BEHAVIORAL Standard Sexual Health Education

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2007-07
Est. Completion 2011-01
Phase NA

What the Registry Record Tells You About NCT01771237

The ClinicalTrials.gov registry entry for NCT01771237 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which MyPeeps Manualized Group Intervention is the first listed.

NCT01771237 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01771237 about?

NCT01771237 is a clinical study titled "HIV Prevention Among Vulnerable Male Youth". This exploratory study aims to design and test an HIV prevention intervention for young men who have sex with men (MSM) between the ages of 16-20 as this group comprises the US adolescent population most at-risk for HIV infection through sexual contact. To help develop the content and format of our ...

What is the current status of trial NCT01771237?

This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2007-07. Estimated completion is 2011-01.

What interventions are being tested in trial NCT01771237?

The interventions under investigation include: MyPeeps Manualized Group Intervention (BEHAVIORAL), Standard Sexual Health Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT01771237?

This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.